[HTML][HTML] The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - ncbi.nlm.nih.gov
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
[引用][C] The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - cir.nii.ac.jp
The molecular mechanisms of chemoresistance in cancers | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - legacy.oncotarget.com
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
[PDF][PDF] The molecular mechanisms of chemoresistance in cancers
HC Zheng - scienceopen.com
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
[PDF][PDF] The molecular mechanisms of chemoresistance in cancers
HC Zheng - pdfs.semanticscholar.org
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - pubmed.ncbi.nlm.nih.gov
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
The molecular mechanisms of chemoresistance in cancers.
HC Zheng - Oncotarget, 2017 - europepmc.org
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
[HTML][HTML] The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - oncotarget.com
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
The molecular mechanisms of chemoresistance in cancers.
HC Zheng - Oncotarget, 2017 - europepmc.org
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …
The molecular mechanisms of chemoresistance in cancers
HC Zheng - Oncotarget, 2017 - oncotarget.com
Overcoming intrinsic and acquired drug resistance is a major challenge in treating cancer
patients because chemoresistance causes recurrence, cancer dissemination and death …
patients because chemoresistance causes recurrence, cancer dissemination and death …